News of the WeekGene Therapy

As Gelsinger Case Ends, Gene Therapy Suffers Another Blow

Science  18 Feb 2005:
Vol. 307, Issue 5712, pp. 1028
DOI: 10.1126/science.307.5712.1028b

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

Five years after 18-year-old Jesse Gelsinger died in a gene therapy experiment, the U.S. Department of Justice has reached a settlement with the researchers and with their institutions.

Related Content